Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity

Pharmacogenetics

Volumn 11, Issue 5, 2001, Pages 417-427

  Wennerholm, A ^a   Johansson, I ^a   Hidestrand, M ^a   Bertilsson, L ^a   Gustafsson, L L ^a   Ingelman Sundberg, M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bufuralol; Debrisoquine; Genetic polymorphism; Single nucleotide polymorphism

Indexed keywords

BUFURALOL; CYTOCHROME P450 2D6; DEBRISOQUINE; GENE PRODUCT; PRIMER DNA;

ALLELE; ARTICLE; CATALYSIS; DRUG METABOLISM; GENE ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HYDROXYLATION; NORMAL HUMAN; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SCREENING; TANZANIA; YEAST CELL; ANIMAL; CELL STRAIN COS1; GENETICS; METABOLISM; NEGRO; SITE DIRECTED MUTAGENESIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANIMALS; CATALYSIS; COS CELLS; CYTOCHROME P-450 CYP2D6; DNA PRIMERS; HUMANS; MUTAGENESIS, SITE-DIRECTED; TANZANIA;

EID: 0034743396     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200107000-00005     Document Type: Article

References (38)

1. Cloning, structure and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme
2. Chimeras of the human cytochrome P450 1A family produced in yeast. Accumulation in microsomal membranes, enzyme kinetics and stability
3. Single-step of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction
4. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH: Cytochrome P450 oxidoreductase
5. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
6. Cytochrome P 450K of rat kidney cortex microsomes: Its involvement in fatty acid - and (-1)-hydroxylation
7. SV40-transformed simian cells support the replication of early SV40 mutants
8. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences
9. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population
10. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
11. A fatty acid gamma-hydroxylation system solubilized from porcine kidney cortex microsomes
12. Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine
13. Genetic analysis of the Chinese cytochrome P4502D locus: Characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation
14. The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of a polymorphic CYP2D6 gene, a related gene, and a pseudogene
15. High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver
16. High yield expression of functionally active human liver CYP2D6 in yeast cells
17. Modulation of 25-hydroxyvitamin D3-24-hydroxylase by aminophylline: A cytochrome P-450 monooxygenase system
18. Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: Structural studies on specific CYP2D6 substrate metabolism
19. Protein measurements with the Folin phenol reagent
20. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
21. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: Characterization of 48 mutations and 53 alleles, their frequencies and evolution
22. A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: Association with diminished debrisoquine hydroxylase activity
23. Genetic polymorphism of drug metabolising enzymes in African populations - Implications for the use of neuroleptics and antidepressants
24. Sequence requirements for cytochrome P-450IID1 catalytic activity
25. The carbon monoxide-binding pigment of liver microsomes, I. Evidence of its hemoprotein nature
26. A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function
27. Elucidation of the genetic basis of the common "intermediate metabolizer" phenotype for drug oxidation by CYP2D6
28. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
29. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
30. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis
31. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism
32. Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxydebrisoquine in urine for CYP2D6 phenotyping
33. Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5
34. Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells
35. Decreased capacity for debrisoquine metabolism among black Tanzanians: Analyses of the CYP2D6 genotype and phenotype
36. Some properties of a detergentsolubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography
37. Selective fast degradation of cytochrome P-450 2E1 in serum-deprived hepatoma cells by a mechanism sensitive to inhibitors of vesicular transport
38. Expression of bovine 17a-hydroxylase cytochtome P-450 cDNA in nonsteroidogenic (COS 1) cells